The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (4 analysts) rates it hold, with a mean price target of $62.
Innovative Industrial Properties, Inc.
IIPR · the NYSE · USD · Market cap $1.6B · 23 employees
Innovative Industrial Properties, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-08-27
Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Innovative Industrial Properties, Inc. holds its Markdown at $56.42. Consolidating, no directional conviction, held for 16 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 16 days |
| Price at the screen | $56.42 |
| Valuation | 12.76 trailing · 12.85 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.40 |
Five Screens, Shown in Full
Does not pass. Revenue purity
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 16.58% | Below 33% | Interest-bearing debt is just 16.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 2.00% | Below 33% | Cash held in interest-bearing accounts and securities is 2.0% of assets, under the one-third limit. | Pass |
| Receivables | 7.04% | Below 49% | Money owed to the company is 7.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 5.38% | Below 5% | 5.4% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. The price runs 13.1% above the base estimate.
Third-party analyst targets: 4 covering, consensus Hold. The average target sits +4% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsA landlord betting on niche warehouses as rents fade
Picture a property owner who bought up specialised industrial sites just as demand from key tenants started easing. Innovative Industrial Properties owns and manages these facilities across the US, yet revenue is already shrinking 4 percent. At a forward multiple of 13.5 times and a return on equity of only 6 percent, the numbers show a business that is stable but not expanding.
We pass because the shares sit just 3 percent below our fair value with no meaningful margin of safety. Analyst targets cluster around 56 dollars, below the current 64-dollar price, and the unknown competitive edge offers little reason to expect faster growth ahead. The ethical screen clears, yet the investment case does not.
Low returns and flatlining revenue leave little room for disappointment if life-science or industrial tenants cut space. Currency or interest-rate moves could add further pressure on a REIT already priced for modest outcomes. Analysis, not advice.
| Forward P/E | 12.9xexpensive even after accounting for its growth |
| Trailing P/E | 12.8xreasonably valued |
| EPS, trailing | 4.42 |
| EPS, forward | 4.39 |
| Revenue growth | +0.7%slow but positive growth |
| Profit margin | 52.3%highly profitable on every dollar of sales |
| Return on equity | 7.4%a modest return on shareholder capital |
| FCF yield | 6.42% |
| Dividend yield | 1,256.00% |
| Debt to equity | 0.33minimal debt: a conservative balance sheet |
| Current ratio | 4.58comfortably covers its short-term bills |
| Beta | 1.40moves a little more than the market |
| Short interest, float | 0.20% |
| 52-week range | 44.58 - 65.38 |
| Market cap | $1.6B |
| Employees | 23 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeIIPR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (4 analysts) rates it hold, with a mean price target of $62.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (4 analysts) rates it hold, with a mean price target of $62.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $56.49 | +4.8% | · | $1,048 | +4.8% |
| 2 months | $51.00 | +16.1% | · | $1,161 | +16.1% |
| 3 months | $51.13 | +15.8% | $1.90 | $1,195 | +19.5% |
| 6 months | $48.25 | +22.7% | $3.80 | $1,306 | +30.6% |
| 1 year | $49.33 | +20.0% | $7.60 | $1,354 | +35.4% |
| 2 years | $84.45 | -29.9% | $15.20 | $881 | -11.9% |
| 3 years | $51.29 | +15.4% | $22.44 | $1,592 | +59.2% |
| 5 years | $125.45 | -52.8% | $35.74 | $757 | -24.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever IIPR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.